Glitazone fears are alleviated

The diabetes drug rosiglitazone does not necessarily increase cardiovascular risk for type-2 diabetics, claim Canadian researchers.

The findings contrast with a reported 60 per cent increased risk of cardiovascular death associated with the drug, which was widely reported last year.

The latest study involved 193 patients with type-2 diabetes who were randomly assigned to receive either 8mg rosiglitazone or a placebo daily for 12 months.

Researchers found that rosiglitazone helps to lower atherosclerosis rates by lowering lipid levels and inflammatory markers.

No episodes of heart failure or any cardiovascular events were noted during the study.

Lead researcher Dr Oliver Bertrand, from Laval University in Quebec, Canada, told delegates at the ACC in Chicago last week that findings provided reassurance about the safety of rosiglitazone in diabetes.

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Social distancing should be cut to 1m in practices, says new IPC guidance

Social distancing should be cut to 1m in practices, says new IPC guidance

Practices can reduce social distancing from 2m to 1m providing the continued use...

Working as a full-time GP in clinical practice is becoming unsafe, RCGP chair warns

Working as a full-time GP in clinical practice is becoming unsafe, RCGP chair warns

The government needs to understand that general practice is a 'safety critical occupation'...

Face-to-face care debate 'too polarised', says NHS England's top GP

Face-to-face care debate 'too polarised', says NHS England's top GP

The face-to-face care debate has become 'too polarised', NHS England's top GP has...

GPs can apply learning from COVID-19 pandemic to fight climate emergency

GPs can apply learning from COVID-19 pandemic to fight climate emergency

GPs can apply learning from the COVID-19 response to help fight the climate emergency...

GP who lost her job to long COVID urges doctors not to underestimate the condition

GP who lost her job to long COVID urges doctors not to underestimate the condition

A GP with long COVID has urged other doctors to listen to patients who have the illness...

GPs must demand strong voice in COVID-19 public inquiry

GPs must demand strong voice in COVID-19 public inquiry

General practice must ensure its voice is heard as national inquiries into the initial...